# BridgeBio Pharma, Inc. (BBIO) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $502M |
| 2024 | $222M |
| 2023 | $9M |
| 2022 | $78M |
| 2021 | $70M |
| 2020 | $8M |
| 2019 | $41M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $195M |
| 2025-09-30 | $121M |
| 2025-06-30 | $111M |
| 2025-03-31 | $117M |
| 2024-09-30 | $3M |
| 2024-06-30 | $2M |
| 2024-03-31 | $211M |
| 2023-09-30 | $4M |
| 2023-06-30 | $2M |
| 2023-03-31 | $2M |
| 2022-09-30 | $338,000 |
| 2022-06-30 | $74M |
| 2022-03-31 | $2M |
| 2021-09-30 | $2M |
| 2021-06-30 | $54M |
| 2021-03-31 | $462,000 |
| 2020-09-30 | $8M |
| 2019-09-30 | $27M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BBIO/revenue)